Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

Jun 8 2022

Drug Commercialization and Launch- Drug Development Series Part 3 of 3

June 8, 2022

2:30 PM - 3:30 PM

Location

Virtual at Cure

ABOUT THE EVENT

In this lecture, we will focus on drug commercialization and early planning for launch to maximize the commercial value of a novel therapeutic. Specific emphasis in the session will be placed on discussing early planning for launch and commercialization, The discussion will also highlighting some of the common pitfalls during commercialization and how to avoid them while you and building an organization for launch success.

Key themes and topics in this session will include:

· Capstone overview of project stage gates from discovery through launch

· Launch planning (how early in development should planning begin)

· Forecasting product launch needs and integrating with manufacture and supply

· Maximizing product value through a successful launch

· Common pitfalls during product commercialization and launch and how to avoid them

· Building an organization to support product launch

Click here for more information

Designed for executives and academics interested in understanding the intricacies of drug development.

Affiliates of Deerfield Management Company, L.P. have a financial interest in Melinta Therapeutics.

SPEAKERS

Christine Miller
President & Chief Executive Officer
Melinta Therapeutics
Molly Deiss
Senior-Level Pharmaceutical Executive, Healthcare Marketing
Melinta Therapeutics

Contact

Cure.

Date posted

May 13, 2022

Date updated

May 13, 2022